NYSE · DG

Dollar General Corp.

$123.22 +$5.99 (+5.11%) 1D After hours

Key Metrics

$25.86B
Market cap
16.53×
P/E · TTM
$43.08B
Revenue · TTM
$1.56B
Net income
EPS · TTM $7.11
Dividend yield 2.0%
Free cash flow $2.20B
Beta · 1Y 0.51
EBITDA · TTM $3.11B
Gross margin 30.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 28
    Money has been moving out of its sector (Consumer Discretionary).

    Consumer Discretionary has run -5.7 points vs SPY over four weeks, ranking 3→5→10→11 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 13
    From its Feb 27 high, the share price fell 35%.

    Peak close $156.24 on Feb 27; trough close $101.75 on May 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -35%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$25.86B
Enterprise value$29.08B
Shares outstanding220.6M
52-wk range$95.11 – $158.23
Avg volume · 20D2.8M
Net cash −$3.22B
Book value / share$40.17
IndustryRetail-Variety Stores
ExchangeNYSE
About Dollar General Corp.
IPO dateNov 13, 2009
Employees194000

Since its beginning in 1939, Dollar General has grown to become the largest dollar store operator in the United States, with more than 20,000 small-box discount stores across 48 states. The firm generated over $42 billion in fiscal 2025 sales.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E16.53
P/S0.60
P/FCF11.75
EV/EBITDA9.36
EV/Sales0.68
Graham №$80.15

Profitability

Gross 30.8%
Operating 4.7%
Net 3.6%
FCF 5.1%
ROE / ROIC 19.2% · 13.0%

Financial Health

Current ratio1.17
Quick ratio0.25
Debt / equity0.52
Debt / EBITDA 1.47
Net cash −$3.22B
Working capital$1.22B

Cash Flow · TTM

Operating CF $3.50B
Capex −$1.30B
Free cash flow $2.20B
Buybacks
Dividends paid $519.84M
Shareholder yield 2.0%

Piotroski F-Score

7 / 9
Strong fundamentals · 7 of 9 signals passing

Altman Z-Score

2.5
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$80.15 vs $123.22
Trades 1.5× above classic defensive value — priced for growth
Fundamentals through 2026-05-01 · computed by TickerWolf from SEC filings